Regenerative medicines are headed for people with Parkinson’s disease or severe heart failure — but researchers are concerned about minimal clinical-trial data.
Japan Approves Worlds First iPS Therapies for Parkinsons, Heart Failure Conditional approval granted for Sumitomo Pharmas ...
A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months. A ...
Conditional genetics and single-embryo RNA-seq show that SETDB1 extinguishes the transient, retroelement-driven transcriptional programs of the totipotent two-cell state to facilitate the exit from ...
Hosted on MSN
Reprogram your mind with Bob Proctor to experience a complete transformation, empowering you to silence any doubters
Absolute Motivation offers original speeches from excellent speakers designed to provide the motivation, knowledge, and boost needed to change your life, overcome hard times, and reach the next level.
Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE) and the Ludwig Institute for Cancer Research have discovered that neutrophils, a ...
The squishy insoles in your favorite pair of sneakers help keep your joints safe from daily wear-and-tear, but over time, that cushioning wears down. The same goes for your cartilage—the fibrous ...
Age-related memory decline and neurodegenerative diseases like Alzheimer's are often thought of as irreversible. But the brain is not static; neurons continually adjust the strength of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results